Filing metadata

Accession number
0000902664-23-002379
Form type
Form 4
Filer
Milestone Pharmaceuticals Inc.
CIK
CIK 1408443
Filed
Mar 24, 2023
Reporting period
Mar 22, 2023
Description
Insider transaction

Explore SEC Filings Hub